OBSS CodeMaster expands into the UK, coding contest takes place in Oxford & Cambridge with €30,000 grand prize
03 mars 2023 07h00 HE
|
OBSS TEKNOLOJI ANONIM SIRKETI
Software development and technology company OBSS Technology, conducts CodeMaster coding contest with a legacy of more than 10 years. On its 11th year, OBSS CodeMaster online coding contest expands...
Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner
07 févr. 2023 04h00 HE
|
Oxford Science Enterprises
Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner Oxford, UK: February 7, 2023 – Oxford Science Enterprises (OSE), the independent...
Imbria Presents Positive Clinical Data for Ninerafaxstat from IMPROVE-DiCE at the European Society of Cardiology Congress 2022
26 août 2022 08h15 HE
|
Imbria Pharmaceuticals Inc.
BOSTON, Mass., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today...
Blue Water Vaccines Announces Closing of Initial Public Offering
23 févr. 2022 16h51 HE
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing...
Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering
17 févr. 2022 19h22 HE
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the...
The Blood Connection joins nation’s first emergency blood reserve
02 déc. 2021 11h25 HE
|
The Blood Connection
THE CAROLINAS AND GEORGIA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Facing an increasingly unsteady blood supply, The Blood Connection has helped establish a first-in-the-nation partnership to prepare The...
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development
10 févr. 2021 03h00 HE
|
SpyBiotech
SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technologyBraavos Investment Advisers led the round, joined by new investor...
Atos s'associe à l'Université d'Oxford pour l’installation du plus grand supercalculateur IA du Royaume-Uni
04 août 2020 04h00 HE
|
Atos International
Paris et Londres, le 4 août 2020 - Atos, leader international de la transformation digitale, a signé un contrat de quatre ans et d'une valeur de 5 millions de livres sterling avec l'Université...
Atos partners with University of Oxford on largest AI supercomputer in the UK
04 août 2020 04h00 HE
|
Atos International
Paris and London, 4 August 2020 – Atos, a global leader in digital transformation, has signed a four-year contract worth £5 million with the University of Oxford to deliver a new, state of the art,...
ObsEva Reports Second Quarter 2019 Financial Results
07 août 2019 01h00 HE
|
ObsEva SA
Multiple Major Milestones Expected This Year- Q4:19 Phase 3 data for IMPLANT 4 trial of nolasiban - Nolasiban MAA submission targeted for year- end 2019- Q4:19 Phase 3 data for...